Online pharmaceutical platform PharmaCube has released a new report tracing the sweeping evolution of China's innovative drug ...

The pharmaceutical sector dominates end-user demand, accounting for 44.7% of the Japanese healthcare and laboratory label ...

Pfizer Inc. Chief Executive Albert Bourla said the company secured a three-year grace period from President Trump’s promised tariffs on pharmaceuticals in a deal that would lower some of the company’s ...

Trump’s sweeping 100% pharmaceutical tariff starting October 1 triggers massive $270 billion industry investment surge, creating clear stock market winners like Eli Lilly while foreign-dependent ...

AstraZeneca AZN1.05%increase; green up pointing triangle said it will offer its asthma and diabetes drugs at an up to 70% discount in the U.S. ahead of a Trump administration deadline for ...

Vaccine-maker Moderna has opened a new manufacturing base in Oxfordshire in a boost to the pharmaceutical industry after other major firms shelved or paused planned UK investments this year. The ...

Global drugmakers including Merck & Co., Eli Lilly & Co. and AstraZeneca Plc are pausing or canceling investments in the UK while throwing barbs at the lack of competitiveness of its business ...

A series of statements and funding cuts suggest that the UK pharmaceutical industry and research sector is losing its competitive edge. First, Merck said on 10 September that it was scrapping a plan ...

The Trump administration is cracking down on pharmaceutical advertising—but stopped short of the worst-case scenario some drug and ad executives feared. The moves could dent, but not demolish, the ...

The era of direct-to-consumer (DTC) pharmaceutical commercials may be coming to a close. On September 9, President Donald Trump signed a memorandum ordering the Food and Drug Administration (FDA) to ...